• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用CANHEART健康指数评估小儿肥厚型心肌病的心血管健康状况。

Assessing Cardiovascular Health in Paediatric Hypertrophic Cardiomyopathy Using the CANHEART Health Index.

作者信息

Srbely Victoria, Jeewa Aamir, Pidborochynski Tara, Lemaire-Paquette Samuel, Khoury Michael, Cunningham Chentel, Dhillon Santokh, Laroussi Nassiba Alami, Vaujois Laurence, Dallaire Frederic, Schantz Daryl, Armstrong Kathryn, Mawad Wadi, Bradley Timothy, Conway Jennifer

机构信息

School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.

Department of Pediatrics, Division of Cardiology, the Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

CJC Pediatr Congenit Heart Dis. 2024 Jul 8;3(5):183-190. doi: 10.1016/j.cjcpc.2024.06.002. eCollection 2024 Oct.

DOI:10.1016/j.cjcpc.2024.06.002
PMID:39619007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11602625/
Abstract

BACKGROUND

Paediatric hypertrophic cardiomyopathy (HCM) is associated with sudden cardiac death, often resulting in restriction of strenuous physical activity. High levels of inactivity and a rise in youth obesity may increase risk of poor cardiovascular (CV) health in these patients. We aim to compare the CV disease risk profile of paediatric patients with HCM to Canadian youth.

METHODS

Patients with HCM (10-19 years) were recruited from 10 paediatric cardiac centres in Canada. The CV disease risk profile was determined using the Healthy Hearts School Program questionnaire and Cardiovascular Health in Ambulatory Care Research Team (CANHEART) health index. Poisson regressions were used to assess associations between the CV disease risk profile of paediatric patients with HCM and the overall CANHEART health score.

RESULTS

A total of 56 subjects were enrolled (71% male, median age: 15.5 years [interquartile range: 13.8-16.8], median body mass index: 23.3 [interquartile range: 19.5-27.7]). Results of the CANHEART health index revealed that 89% of participants with HCM never tried smoking, 52% had a healthy body mass index, 39% consumed ≥5 fruits/vegetables per day, and 50% engaged in ≥60 minutes of walking or 20 minutes of running/jogging per day. When CANHEART intermediate and poor health index scores were combined, similar proportions were obtained for each group (HCM 82.1% vs Canadian youth 83.4%;  = 0.724).

CONCLUSIONS

Many paediatric patients with HCM in Canada have intermediate or poor CV health as determined by the CANHEART health score, with high rates of obesity and low physical activity levels driving these trends. Interventions should be developed to promote positive CV health behaviours among patients with HCM.

摘要

背景

小儿肥厚型心肌病(HCM)与心源性猝死相关,常导致剧烈体育活动受限。高水平的不活动和青少年肥胖率上升可能增加这些患者心血管(CV)健康不良的风险。我们旨在比较小儿HCM患者与加拿大青少年的心血管疾病风险状况。

方法

从加拿大10个儿科心脏中心招募10 - 19岁的HCM患者。使用健康心脏学校项目问卷和门诊护理研究团队心血管健康(CANHEART)健康指数确定心血管疾病风险状况。采用泊松回归评估小儿HCM患者的心血管疾病风险状况与CANHEART总体健康评分之间的关联。

结果

共纳入56名受试者(71%为男性,中位年龄:15.5岁[四分位间距:13.8 - 16.8],中位体重指数:23.3[四分位间距:19.5 - 27.7])。CANHEART健康指数结果显示,89%的HCM参与者从未尝试吸烟,52%的人具有健康的体重指数,39%的人每天食用≥5份水果/蔬菜,50%的人每天进行≥60分钟的步行或20分钟的跑步/慢跑。当将CANHEART中等和较差健康指数评分合并时,每组获得的比例相似(HCM为82.1%,加拿大青少年为83.4%;P = 0.724)。

结论

根据CANHEART健康评分,加拿大许多小儿HCM患者的心血管健康处于中等或较差水平,肥胖率高和身体活动水平低推动了这些趋势。应制定干预措施,以促进HCM患者形成积极的心血管健康行为。

相似文献

1
Assessing Cardiovascular Health in Paediatric Hypertrophic Cardiomyopathy Using the CANHEART Health Index.使用CANHEART健康指数评估小儿肥厚型心肌病的心血管健康状况。
CJC Pediatr Congenit Heart Dis. 2024 Jul 8;3(5):183-190. doi: 10.1016/j.cjcpc.2024.06.002. eCollection 2024 Oct.
2
The CANHEART health index: a tool for monitoring the cardiovascular health of the Canadian population.CANHEART 健康指数:监测加拿大人口心血管健康的工具。
CMAJ. 2014 Feb 18;186(3):180-7. doi: 10.1503/cmaj.131358. Epub 2013 Dec 23.
3
Evaluation of new predictive scores for sudden cardiac death in childhood hypertrophic cardiomyopathy in a French cohort.评估新的预测评分在法国队列儿童肥厚型心肌病中的心脏性猝死。
Arch Cardiovasc Dis. 2024 Jun-Jul;117(6-7):402-408. doi: 10.1016/j.acvd.2024.03.003. Epub 2024 May 18.
4
Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.梗阻性肥厚型心肌病患者纽约心功能协会分级随时间变化的心血管结局:一项回顾性队列研究。
J Med Econ. 2023 Jan-Dec;26(1):1495-1506. doi: 10.1080/13696998.2023.2277076. Epub 2023 Nov 30.
5
Modifiable cardiovascular risk factors in adolescents and adults with congenital heart disease.先天性心脏病青少年和成人中可改变的心血管危险因素。
Congenit Heart Dis. 2018 Jul;13(4):563-570. doi: 10.1111/chd.12612. Epub 2018 Jun 25.
6
Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.儿童 RAS 相关肥厚型心肌病中的心源性猝死:HCM 风险儿童模型的验证和事件预测因子。
Int J Cardiol. 2023 Dec 15;393:131405. doi: 10.1016/j.ijcard.2023.131405. Epub 2023 Sep 28.
7
Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score.儿童肥厚型心肌病中心脏性猝死最好通过心电图风险评分和 HCMRisk-Kids 评分的组合来预测。
Acta Paediatr. 2021 Nov;110(11):3105-3115. doi: 10.1111/apa.16045. Epub 2021 Aug 19.
8
[Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].[2014年欧洲指南心脏性猝死风险预测模型(HCM Risk-SCD)对中国肥厚型心肌病患者的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1033-1038. doi: 10.3760/cma.j.issn.0253-3758.2017.12.006.
9
Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.青少年左心室肥厚与肥厚型心肌病的鉴别:一项纵向观察研究。
Eur J Prev Cardiol. 2024 Mar 27;31(5):591-598. doi: 10.1093/eurjpc/zwad361.
10
Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.利用国家电子健康记录识别肥厚型心肌病中未满足的临床需求。
PLoS One. 2018 Jan 11;13(1):e0191214. doi: 10.1371/journal.pone.0191214. eCollection 2018.

引用本文的文献

1
Sex Differences in Cardiovascular Health Status and Long-Term Outcomes in a Primary Prevention Cohort.初级预防队列中心血管健康状况和长期结局的性别差异。
JACC Adv. 2025 Sep 1;4(10 Pt 2):102108. doi: 10.1016/j.jacadv.2025.102108.
2
Feasibility of an Individualized Exercise Training Program for Children with Hypertrophic Cardiomyopathy.肥厚型心肌病患儿个体化运动训练计划的可行性
Pediatr Cardiol. 2025 Apr 15. doi: 10.1007/s00246-025-03843-3.
3
Modifiable Health Behaviours in Children with HCM: Lessons from the Heart Health Survey.肥厚型心肌病患儿可改变的健康行为:来自心脏健康调查的经验教训。
Pediatr Cardiol. 2025 Jan 8. doi: 10.1007/s00246-024-03746-9.

本文引用的文献

1
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者的剧烈运动。
JAMA Cardiol. 2023 Jun 1;8(6):595-605. doi: 10.1001/jamacardio.2023.1042.
2
Use of Photovoice to Explore Pediatric Patients with Hypertrophic Cardiomyopathy and their Parents' Perceptions of a Heart-Healthy Lifestyle.运用影像叙事法探究肥厚型心肌病患儿及其家长对健康生活方式的认知
J Am Heart Assoc. 2022 Apr 5;11(7):e023572. doi: 10.1161/JAHA.121.023572. Epub 2022 Mar 18.
3
The Canadian Pediatric Cardiology Research Network: A Model National Data-Sharing Organization to Facilitate the Study of Pediatric Heart Diseases.加拿大儿科心脏病学研究网络:一个促进儿科心脏病研究的全国性数据共享组织典范。
CJC Open. 2020 Nov 26;3(4):510-515. doi: 10.1016/j.cjco.2020.11.014. eCollection 2021 Apr.
4
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
5
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.安大略省年轻人肥厚型心肌病相关心源性猝死。
Circulation. 2019 Nov 19;140(21):1706-1716. doi: 10.1161/CIRCULATIONAHA.119.040271. Epub 2019 Oct 21.
6
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
7
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
8
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC).欧洲预防心脏病学会运动心脏病学分会关于心肌病、心肌炎和心包炎运动员参与竞技和休闲运动的建议声明。
Eur Heart J. 2019 Jan 1;40(1):19-33. doi: 10.1093/eurheartj/ehy730.
9
Modifiable cardiovascular risk factors in adolescents and adults with congenital heart disease.先天性心脏病青少年和成人中可改变的心血管危险因素。
Congenit Heart Dis. 2018 Jul;13(4):563-570. doi: 10.1111/chd.12612. Epub 2018 Jun 25.
10
Hypertrophic Cardiomyopathy: Clinical Update.肥厚型心肌病:临床更新。
JACC Heart Fail. 2018 May;6(5):364-375. doi: 10.1016/j.jchf.2018.02.010. Epub 2018 Apr 11.